Literature DB >> 1693699

Paramyxovirus membrane protein enhances antibody production to new antigenic determinants in the actin molecule: a model for virus-induced autoimmunity.

W T Anomasiri1, D R Tovell, D L Tyrrell.   

Abstract

Paramyxovirus membrane (M) protein specifically binds to cellular actin but not to bovine serum albumin or myoglobin, as determined by affinity chromatography and enzyme-linked immunosorbent assay. The binding site for M protein on actin is different from the binding sites for antiactin antibodies. The interaction of M protein with actin resulted in production of antibodies to several new antigenic sites on the actin molecule. Five rabbits immunized with actin alone produced antibodies against the N-terminal sequence (residues 1 to 39). Another five rabbits immunized with a mixture of M protein and actin produced antibodies against a C-terminal fragment and a central region as well as the N-terminal fragment. By immunoblotting with proteolytic fragments of actin, the new antigenic sites were located between amino acid residues 40 to 113, 114 to 226, and 227 to 375. Antisera taken from some patients with recent measles virus infections demonstrated antiactin antibodies to sites other than the N-terminal fragment of actin (amino acids 1 to 39). The interaction of paramyxovirus M protein with actin and the subsequent production of antibodies to new antigenic sites may serve as a model for one of the mechanisms of virus-induced autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693699      PMCID: PMC249522     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites.

Authors:  J M Parker; D Guo; R S Hodges
Journal:  Biochemistry       Date:  1986-09-23       Impact factor: 3.162

2.  Structural variations in actins. A study of the immunological reactivity of the N-terminal region.

Authors:  C Roustan; Y Benyamin; M Boyer; J C Cavadore
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

3.  Conformational changes induced by Mg2+ on actin monomers. An immunologic attempt to localize the affected region.

Authors:  C Roustan; Y Benyamin; M Boyer; R Bertrand; E Audemard; J Jauregui-Adell
Journal:  FEBS Lett       Date:  1985-02-11       Impact factor: 4.124

4.  Mice immunized with measles virus develop antibodies to a cell surface receptor for binding virus.

Authors:  D L Krah; P W Choppin
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

5.  Molecular mimicry and autoimmune disease.

Authors:  M B Oldstone
Journal:  Cell       Date:  1987-09-11       Impact factor: 41.582

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Anti-actin antibodies. Detection and quantitation of total and skeletal muscle actin in human plasma using a competitive ELISA.

Authors:  C Mejean; C Roustan; Y Benyamin
Journal:  J Immunol Methods       Date:  1987-05-04       Impact factor: 2.303

8.  Conditions for reproducible detection of calmodulin and S100 beta in immunoblots.

Authors:  L J Van Eldik; S R Wolchok
Journal:  Biochem Biophys Res Commun       Date:  1984-11-14       Impact factor: 3.575

9.  Paramyxovirus membrane protein augments the antibody response to actin in mice.

Authors:  W T Anomasiri; D L Tyrrell
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

10.  Infection of mice with lactate dehydrogenase-elevating virus leads to stimulation of autoantibodies.

Authors:  W A Cafruny; D E Hovinen
Journal:  J Gen Virol       Date:  1988-03       Impact factor: 3.891

View more
  1 in total

Review 1.  Host cytoskeleton in respiratory syncytial virus assembly and budding.

Authors:  Shadi Shahriari; James Gordon; Reena Ghildyal
Journal:  Virol J       Date:  2016-09-26       Impact factor: 4.099

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.